Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Genomics|March 7, 2003
Candidate tumor suppressor genes at FRA7G are coamplified with MET and do not suppress malignancy in a gastric cancerShuang-Yin Han, Teresa Druck, Kay HuebnerCurrent Pharmaceutical Design|December 29, 2017
Safety Strategies of Genetically Engineered T Cells in Cancer ImmunotherapyYan-Bei Ren, Shang-Jun Sun, Shuang-Yin HanArchives of Medical Science : AMS|September 15, 2021
Mesothelin-targeted CAR-T cells for adoptive cell therapy of solid tumorsGui-Zhen Zhang, Tian-Fang Li, Shuang-Yin HanCancer Cell International|July 9, 2016
Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinomaE-Na Qian, Shuang-Yin Han, Song-Ze Ding, et al.Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|November 30, 2012
[The analysis of hepatitis delta virus infective markers in the hepatitis is B virus infective people]Po-Shi Xu, Shuang-Yin Han, Chang-Yi Sun, et al.Current Pharmaceutical Design|March 18, 2017
Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of GlioblastomaPei-Pei Ren, Ming Li, Tian-Fang Li, et al.CNS Neuroscience & Therapeutics|January 10, 2018
MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathwayChang Chai, Lai-Jun Song, Shuang-Yin Han, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox expressionDimitrios Iliopoulos, Muller Fabbri, Teresa Druck, et al.Open Medicine (Warsaw, Poland)|November 29, 2023
MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathwayJia-Bei Xie, Hao Zhang, Xiao-Fang Li, et al.Journal of Hematology & Oncology|July 9, 2013
Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challengesEthan Q Han, Xiu-ling Li, Chun-rong Wang, et al.Pageof 5